Creating a new method to stage tuberculosis
Design of an Integrative Algorithm for Staging Tuberculosis to Improve Clinical Management.
Fundació Institut Germans Trias i Pujol · NCT03691883
This study is trying to create a new way to stage tuberculosis by looking at different factors in patients to help improve how the disease is understood and managed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | Fundació Institut Germans Trias i Pujol (other) |
| Locations | 5 sites (Badalona, Barcelona and 4 other locations) |
| Trial ID | NCT03691883 on ClinicalTrials.gov |
What this trial studies
This study focuses on tuberculosis, a chronic infectious disease affecting millions globally, with a significant number of cases in Barcelona. It aims to develop an integrative algorithm for staging tuberculosis by considering various social, psychological, and health-related factors. The approach is observational, gathering data from patients diagnosed with tuberculosis at specific hospitals in Barcelona. The goal is to enhance understanding and management of the disease through a comprehensive staging system.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with any form of tuberculosis who have microbiological confirmation of their condition.
Not a fit: Patients who do not consent to data or sample donation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of tuberculosis, ultimately enhancing patient outcomes.
How similar studies have performed: While there have been various approaches to tuberculosis management, this integrative algorithm represents a novel method that has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * TB diagnosis (all forms), microbiologically confirmed (by AFB+, GenXpert+ or Culture+) * Clinical management of the patients being done at Servicios Clínicos, Hospital Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans Trias i Pujol. Exclusion Criteria: * Not consenting to data/samples donation
Where this trial is running
Badalona, Barcelona and 4 other locations
- Hospital Universitari Germans Trias i Pujol — Badalona, Barcelona, Spain (RECRUITING)
- Hospital Sant Joan de Déu — Esplugues de Llobregat, Barcelona, Spain (RECRUITING)
- Hospital del Mar — Barcelona, Spain (RECRUITING)
- Hospital Universitari Vall d'Hebron-Drassanes — Barcelona, Spain (RECRUITING)
- Servicios Clínicos de Barcelona — Barcelona, Spain (RECRUITING)
Study contacts
- Principal investigator: Cris Vilaplana, MD, PhD — Fundació Institut Germans Trias i Pujol
- Study coordinator: Cris Vilaplana, MD, PhD
- Email: cvilaplana@gmail.com
- Phone: 934978677
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Tuberculosis, tuberculosis, infectious diseases